Podcast Episode

Myeloproliferative Neoplasms (MPNs): New Therapies, New Hope

Catriona Jamieson, MD, PhD

Myeloproliferative neoplasms (MPNs) are rare blood cancers that alter how the body produces blood cells, requiring individualized care. In this episode, Catriona Jamieson, MD, PhD, of the University of California San Diego, shares the latest breakthroughs in MPN research, from detecting disease progression earlier to developing targeted, personalized therapies.

We explore MPN subtypes, the role of genetic testing, and current and emerging therapies. Whether you are navigating polycythemia vera (PV), essential thrombocythemia (ET), or myelofibrosis (MF), this conversation offers practical insights into today’s care landscape and new reasons for hope.

CLICK HERE to participate in our episode survey.

Mentioned on this episode: 

Additional Blood Cancer United Support Resources: 

Episode supported by Novartis Pharmaceuticals Corporation; PharmaEssentia USA Corporation; and Takeda Oncology.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top